Bambusa Therapeutics, Inc.

BBTX chart

Bambusa Therapeutics, Inc. news

• Bambusa Therapeutics, Inc. (BBTX) Company Information

  Simply Wall St · Nov 1, 1:26 AM EDT

• BBTX SEC Filings - Bambusa Therapeutics, Inc.

  Stock Titan · Oct 31, 9:34 PM EDT

• Bambusa Therapeutics (BBTX) Stock Price, News & Analysis

  MarketBeat · Oct 31, 7:13 PM EDT

• Wilson Sonsini Advises Bambusa Therapeutics on $168.9 Million Initial Public Offering

  Wilson Sonsini · Oct 31, 3:42 AM EDT

• Bambusa IPO Falls 6.3% After $168.9M Offering

  Briefs Finance · Oct 30, 7:19 PM EDT

• Bambusa Therapeutics, Inc. (BBTX) Stock Price, News & Analyst Forecast

  eToro · Oct 30, 4:10 PM EDT

• Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO

  Latham & Watkins LLP · Oct 30, 3:17 PM EDT

• Bambusa Therapeutics goes public after raising nearly $169M

  The Business Journals · Oct 30, 12:01 PM EDT

• Bambusa Therapeutics, Inc. (BBTX) interactive stock chart

  Yahoo Finance UK · Oct 30, 11:51 AM EDT

• Bambusa Therapeutics Rings the Nasdaq Stock Market Opening Bell

  Nasdaq · Oct 30, 9:59 AM EDT

• Bambusa Therapeutics, Inc. Common stock (BBTX) stock price, news, quote and history

  Yahoo Finance Singapore · Oct 30, 8:36 AM EDT

• Bambusa Therapeutics prices upsized IPO at $16 per share

  TradingView · Oct 30, 8:05 AM EDT

Bambusa Therapeutics, Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• S-1S-12026-10-09

About Bambusa Therapeutics, Inc.

Ticker

BBTX (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2044950

Frequently asked questions